# Ticagrelor for PCI Post Thrombolysis

> **NCT01930591** · PHASE3 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 140 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01930591
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-10
- **Final completion:** 2016-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2016-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930591, "Ticagrelor for PCI Post Thrombolysis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01930591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*